Why the study?
Does a histological score tool reliably quantify disease severity in muscle biopsies of patients with juvenile dermatomyositis and correlate with clinical measures?
Does a histological score tool reliably quantify disease severity in muscle biopsies of patients with juvenile dermatomyositis and correlate with clinical measures?
A modified histological score tool for juvenile dermatomyositis muscle biopsies demonstrates high reliability and correlates well with clinical disease activity, supporting its use in diagnostics and clinical trials.
Answers are grounded in this paper and cite their sources.
Supports reliable histological scoring in juvenile dermatomyositis; leaves open larger prospective validation before routine use.
OBJECTIVES: To study muscle biopsy tissue from patients with juvenile dermatomyositis (JDM) in order to test the reliability of a score tool designed to quantify the severity of histological abnormalities when applied to biceps humeri in addition to quadriceps femoris. Additionally, to evaluate whether elements of the tool correlate with clinical measures of disease severity. METHODS: 55 patients with JDM with muscle biopsy tissue and clinical data available were included. Biopsy samples (33 quadriceps, 22 biceps) were prepared and stained using standardised protocols. A Latin square design was used by the International Juvenile Dermatomyositis Biopsy Consensus Group to score cases using our previously published score tool. Reliability was assessed by intraclass correlation coefficient (ICC) and scorer agreement (α) by assessing variation in scorers' ratings. Scores from the most reliable tool items correlated with clinical measures of disease activity at the time of biopsy. RESULTS: Inter- and intraobserver agreement was good or high for many tool items, including overall assessment of severity using a Visual Analogue Scale. The tool functioned equally well on biceps and quadriceps samples. A modified tool using the most reliable score items showed good correlation with measures of disease activity. CONCLUSIONS: The JDM biopsy score tool has high inter- and intraobserver agreement and can be used on both biceps and quadriceps muscle tissue. Importantly, the modified tool correlates well with clinical measures of disease activity. We propose that standardised assessment of muscle biopsy tissue should be considered in diagnostic investigation and clinical trials in JDM.
No takes yet. Share an insight, caveat, or question.
Varsani et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: